StockVS

Veeva Systems Inc. (VEEV) Stock Analysis

Healthcare

Veeva Systems Inc.

$158.54

$-1.63 (-1.02%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Veeva Systems Inc. operates as a provider of cloud-based software solutions specifically tailored for the life sciences industry, serving markets across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company functions within the Healthcare sector, specifically classified under the Health Information Services industry, which signifies its role in managing critical data and workflows for pharmaceutical and biotechnology entities. This entity commands a substantial market capitalization of $30.51B, generating annual revenue of $3.20B, while specific employee count data is not publicly disclosed in the provided records. The scale indicated by a market cap exceeding $30 billion and revenue nearing $3.2 billion suggests that Veeva Systems Inc. holds a significant position within its niche, acting as a major infrastructure provider for global drug development and commercialization processes.

Financial Health

Veeva Systems Inc. reported a trailing twelve-month revenue of $3.20B and recorded a net income of $908.91M, with an EBITDA figure standing at $984.97M. The substantial gap between the $3.20B revenue and the $908.91M net income reveals a robust cost structure where operating expenses and taxes consume approximately 71.6% of total revenue, a characteristic typical of high-growth technology firms with significant R&D and sales overhead. The company generated free cash flow of $1.05B, a figure that provides a strong buffer for financial flexibility, allowing the firm to fund internal expansion or acquisitions without immediate reliance on external capital markets. Profitability is further evidenced by a gross margin of 75.5%, indicating high pricing power and efficient production of software licenses, alongside an operating margin of 29.4% and a profit margin of 28.4% that demonstrate effective cost management before and after tax expenses. The balance sheet is characterized by a conservative stance, holding $6.56B in cash against a minimal debt load of $95.86M, resulting in a debt-to-equity ratio of 1.33 which reflects a highly liquid and low-leverage position. Short-term liquidity is exceptionally strong with a current ratio of 4.88, signifying that the company possesses nearly five times the current assets required to cover its short-term liabilities. Management effectiveness is highlighted by a return on equity of 13.9% and a return on assets of 7.3%, metrics that illustrate the firm's ability to generate substantial returns on shareholder capital and operational assets respectively.

Valuation Assessment

The valuation of Veeva Systems Inc. is reflected in a trailing P/E ratio of 34.12 and a forward P/E of 18.77, where the significant disparity between these two figures implies that the market expects earnings to nearly double in the near future to justify the current high multiple. The price-to-book ratio stands at 4.23, indicating that the stock trades at a substantial premium over its book value, a common characteristic for software companies with high intangible assets and intellectual property. Alternative valuation metrics include a price-to-sales ratio of 9.55 and an EV/EBITDA of 24.40, which suggest that the market is willing to pay a high multiple for every dollar of revenue and earnings due to the perceived stability and growth potential of the cash-generating business. The stock has traded between a 52-week low of $168.14 and a 52-week high of $310.50, and given the forward P/E of 18.77 versus the trailing P/E of 34.12, the market is pricing in aggressive future earnings acceleration rather than current price proximity to historical highs. The beta value of 1.12 indicates that the stock exhibits volatility slightly higher than the broader market, suggesting that price movements will be amplified relative to general market shifts during periods of economic uncertainty or sector rotation.

Growth & Income

Veeva Systems Inc. demonstrated revenue growth of 16.0% year-over-year and earnings growth of 23.5% year-over-year, indicating that earnings are expanding at a faster rate than revenue, which typically implies improving operating leverage and margin expansion as the company scales. As a non-dividend payer, the company maintains a dividend yield of N/A and a payout ratio of 0.0%, meaning that all generated earnings are retained and reinvested directly into business growth initiatives rather than being distributed to shareholders. This reinvestment strategy is consistent with the high free cash flow generation and supports the forward-looking valuation metrics that suggest significant future earnings potential. The overall growth and income profile is defined by a high-growth, zero-dividend model that prioritizes capital allocation toward expanding market share and technological innovation over current income distribution.

Peer Comparison

Veeva Systems Inc. (VEEV) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Veeva Systems Inc. VEEV $25.87B 29.1
BrightSpring Health Services, Inc. BTSG $11.70B 78.3
Tempus AI, Inc. TEM $8.38B N/A
HealthEquity, Inc. HQY $7.31B 35.5

The Health Information Services industry average P/E ratio is 57.5x. Veeva Systems Inc. trades at a P/E of 29.1.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Visit website →

Key Statistics

Market Cap
$25.87B
P/E Ratio
29.14
52-Week High
$310.50
52-Week Low
$148.05
Avg Volume
2.92M
Beta
0.92

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
7,928